Syrris Joins Select Group of R&D 100 Award Winners
News Jul 13, 2012
As the longest established provider of laboratory scale flow chemistry systems, Syrris’ wealth of expertise in research and development - as well as its patented technologies - has propelled the modular Asia product line to the forefront of the flow chemistry market.
Designed by chemists, for chemists, Asia enables an extensive range of chemical reactions, at a wide range of temperatures and pressures, with different levels of automation to suit individual laboratory needs.
The esteemed R&D 100 Awards are a benchmark of excellence, with winners chosen by an independent panel of judges and the editors of R&D Magazine.
This award recognizes the significance of flow chemistry and, in particular, Syrris’ contribution to a technology that is enabling chemists to perform faster, safer and cleaner reactions.
Syrris’ success was achieved by establishing that the Asia flow chemistry system improves upon existing technologies, providing evidence of the system’s benefits, including its modularity and wide range of chemical compatibility, and demonstrating how this technology is proving a useful tool for chemists working in such diverse areas as academia and the pharmaceutical, petrochemical and nanoparticle industries.
Mike Hawes, CEO of Syrris, commented: “We are delighted that the Asia system has been announced as a winner of the 50th Annual R&D Awards, acknowledging the success of this groundbreaking technology, and look forward to attending the presentation ceremony in November.”
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Comments | 0 ADD COMMENT
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018